Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Metadata
Title
Characteristics of current benzodiazepine users as indicators of differences in physical and mental health
Authors
Rolf van Hulten
K. Bart Teeuw
Arnold B. Bakker
Albert Bakker
Hubert G. Leufkens
Publication date
01-06-2000
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 3/2000
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1023/A:1008749220107

Other articles of this Issue 3/2000

International Journal of Clinical Pharmacy 3/2000 Go to the issue

Legacy

Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit

Legacy

A national database for essential drugs in South Africa

Legacy

Evaluation of the impact of pharmacist's advice giving on the outcomes of self-medication in patients suffering from dyspepsia

Legacy

Distribution of pharmaceuticals − a Norwegian logistic perspective

Legacy

A review of the technical aspects of drug nebulization

OriginalPaper

In Memoriam
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits